These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 10903191

  • 21. Body composition during GH treatment in Prader-Labhardt-Willi syndrome.
    Bosio L, Beccaria L, Benzi F, Sanzari A, Chiumello G.
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():351-3. PubMed ID: 10698601
    [Abstract] [Full Text] [Related]

  • 22. Final height in children with idiopathic growth hormone deficiency treated with a fixed dose of recombinant growth hormone.
    Rachmiel M, Rota V, Atenafu E, Daneman D, Hamilton J.
    Horm Res; 2007 Apr; 68(5):236-43. PubMed ID: 17396034
    [Abstract] [Full Text] [Related]

  • 23. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD.
    Lange M, Müller J, Svendsen OL, Kastrup KW, Juul A, Feldt-Rasmussen U.
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):18-23. PubMed ID: 15638865
    [Abstract] [Full Text] [Related]

  • 24. [Growth hormone therapy in children with growth hormone deficiency: study of dose-response relationship].
    Lebl J, Zemková D, Kolousková S, Snajderová M.
    Cas Lek Cesk; 1994 Apr 18; 133(8):237-41. PubMed ID: 8194087
    [Abstract] [Full Text] [Related]

  • 25. Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader-Willi syndrome.
    Festen DA, Wevers M, Lindgren AC, Böhm B, Otten BJ, Wit JM, Duivenvoorden HJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2008 Jun 18; 68(6):919-25. PubMed ID: 18031326
    [Abstract] [Full Text] [Related]

  • 26. Serum leptin and IGF-I during growth hormone treatment in chronic renal failure.
    Patel L, Webb NJ, Bradbury MG, Zaman N, Smith P, Lewis MA, Postlethwaite RJ, Price DA, Clayton PE.
    Pediatr Nephrol; 2002 Aug 18; 17(8):643-7. PubMed ID: 12185474
    [Abstract] [Full Text] [Related]

  • 27. Growth hormone treatment in prepubertal children with celiac disease and growth hormone deficiency.
    Giovenale D, Meazza C, Cardinale GM, Farinelli E, Mastrangelo C, Messini B, Citro G, Del Vecchio M, Di Maio S, Possenti I, Bozzola M.
    J Pediatr Gastroenterol Nutr; 2007 Oct 18; 45(4):433-7. PubMed ID: 18030209
    [Abstract] [Full Text] [Related]

  • 28. Adult height in growth hormone deficiency: historical perspective and examples from the national cooperative growth study.
    Frindik JP, Baptista J.
    Pediatrics; 1999 Oct 18; 104(4 Pt 2):1000-4. PubMed ID: 10506251
    [Abstract] [Full Text] [Related]

  • 29. Final adult height and body mass index after cure of paediatric Cushing's disease.
    Davies JH, Storr HL, Davies K, Monson JP, Besser GM, Afshar F, Plowman PN, Grossman AB, Savage MO.
    Clin Endocrinol (Oxf); 2005 Apr 18; 62(4):466-72. PubMed ID: 15807878
    [Abstract] [Full Text] [Related]

  • 30. Growth hormone and body composition in children younger than 2 years with Prader-Willi syndrome.
    Eiholzer U, L'allemand D, Schlumpf M, Rousson V, Gasser T, Fusch C.
    J Pediatr; 2004 Jun 18; 144(6):753-8. PubMed ID: 15192622
    [Abstract] [Full Text] [Related]

  • 31. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
    Lagrou K, Xhrouet-Heinrichs D, Massa G, Vandeweghe M, Bourguignon JP, De Schepper J, de Zegher F, Ernould C, Heinrichs C, Malvaux P, Craen M.
    J Pediatr Endocrinol Metab; 2001 Jun 18; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
    [Abstract] [Full Text] [Related]

  • 32. Catch-up growth in autosomal dominant isolated growth hormone deficiency (IGHD type II).
    Binder G, Iliev DI, Mullis PE, Ranke MB.
    Growth Horm IGF Res; 2007 Jun 18; 17(3):242-8. PubMed ID: 17360215
    [Abstract] [Full Text] [Related]

  • 33. [The use of a biosynthetic human growth hormone in children with a growth hormone deficiency].
    Robles-Valdés C, Altamirano N, Calzada-León R, Llanas-Hernández D, Parás-García G.
    Bol Med Hosp Infant Mex; 1993 Feb 18; 50(2):102-9. PubMed ID: 8442866
    [Abstract] [Full Text] [Related]

  • 34. Five years of growth hormone treatment in children with Prader-Willi syndrome. Swedish National Growth Hormone Advisory Group.
    Lindgren AC, Ritzén EM.
    Acta Paediatr Suppl; 1999 Dec 18; 88(433):109-11. PubMed ID: 10626558
    [Abstract] [Full Text] [Related]

  • 35. Linear growth response to exogenous growth hormone in Prader-Willi syndrome.
    Lee PD, Wilson DM, Rountree L, Hintz RL, Rosenfeld RG.
    Am J Med Genet; 1987 Dec 18; 28(4):865-71. PubMed ID: 3688024
    [Abstract] [Full Text] [Related]

  • 36. [Treatment of somatotropic deficiency with biosynthetic growth hormone].
    Spagnoli A, Bernardini S, Galasso C, Vaccaro F, Manca Bitti ML, Scirè G, Cianfarani S, Spadoni GL.
    Pediatr Med Chir; 1989 Dec 18; 11(4):413-8. PubMed ID: 2694106
    [Abstract] [Full Text] [Related]

  • 37. Auxological and endocrine evolution of 28 children with Prader-Willi syndrome: effect of GH therapy in 14 children.
    Tauber M, Barbeau C, Jouret B, Pienkowski C, Malzac P, Moncla A, Rochiccioli P.
    Horm Res; 2000 Dec 18; 53(6):279-87. PubMed ID: 11146368
    [Abstract] [Full Text] [Related]

  • 38. Dose-response study of biosynthetic human growth hormone (GH) in GH-deficient children: effects on auxological and biochemical parameters. Dutch Growth Hormone Working Group.
    de Muinck Keizer-Schrama SM, Rikken B, Wynne HJ, Hokken-Koelega AC, Wit JM, Bot A, Drop SL.
    J Clin Endocrinol Metab; 1992 Apr 18; 74(4):898-905. PubMed ID: 1548357
    [Abstract] [Full Text] [Related]

  • 39. Low dose growth hormone treatment in infants and toddlers with Prader-Willi syndrome is comparable to higher dosage regimens.
    Scheermeyer E, Harris M, Hughes I, Crock PA, Ambler G, Verge CF, Bergman P, Werther G, Craig ME, Choong CS, Davies PSW, PWS and OZGROW collaboration.
    Growth Horm IGF Res; 2017 Jun 18; 34():1-7. PubMed ID: 28427039
    [Abstract] [Full Text] [Related]

  • 40. Effects of 5 years growth hormone treatment in patients with Prader-Willi syndrome.
    Obata K, Sakazume S, Yoshino A, Murakami N, Sakuta R.
    J Pediatr Endocrinol Metab; 2003 Feb 18; 16(2):155-62. PubMed ID: 12713251
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.